Q9H7Z6 (KAT8_HUMAN) Homo sapiens (Human)
Histone acetyltransferase KAT8 UniProtKBInterProSTRINGInteractive Modelling
458 aa; Sequence (Fasta) ; (Isoform 2; )
No models could be built to increase the coverage beyond existing experimental structures for this target sequence.
Sequence Alignments
Experimental structures
Description | Oligo-state | Ligands | Structure | Range |
---|---|---|---|---|
CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN DOSAGE COMPENSATION FACTORS MSL1 AND MOF |
Heteromer Q6PDM1; | 4×ACO; 4×ZN; | 2y0m | |
Assess | ||||
Crystal structure of human MOF in complex with MSL1 |
Heteromer Q68DK7; | 1×ZN; | 4dnc | |
Assess | ||||
Structural and mechanistical studies of the nuclear import by Importin-alpha |
Heteromer P52292; | 5h43 | ||
Assess | ||||
Human MYST histone acetyltransferase 1 | monomer | 1×ZN; 1×1VU; 1×CL; 4×EDO; | 5wci | |
Assess | ||||
Crystal structure of apo-form human MOF catalytic domain | monomer | 1×ZN; | 3qah | |
Assess | ||||
MYST histone acetyltransferase KAT6A/B in complex with WM-1119 | monomer | 1×FCV; 1×ZN; 1×MG; | 6ct2 | |
Assess | ||||
Crystal structure of MYST acetyltransferase domain in complex with inhibitor 60 | monomer | 1×ML7; 1×ZN; | 6oio | |
Assess | ||||
Crystal structure of MYST acetyltransferase domain in complex with inhibitor CTX-124143 | monomer | 1×ZN; 1×MQJ; 1×GOL; | 6oin | |
Assess | ||||
Crystal structure of MYST acetyltransferase domain in complex with inhibitor 63 | monomer | 1×ZN; 1×MLV; 1×GOL; | 6oiq | |
Assess | ||||
Crystal structure of MYST acetyltransferase domain in complex with inhibitor 34 | monomer | 1×ZN; 2×GOL; 1×MLS; | 6oip | |
Assess | ||||
Crystal structure of MYST acetyltransferase domain in complex with inhibitor | monomer | 1×CL; 1×ZN; 5×GOL; 1×NA; 1×7KM; | 6ba2 | |
Assess | ||||
Crystal structure of MYST acetyltransferase domain in complex with inhibitor 83 | monomer | 1×ZN; 1×NA; 2×GOL; 1×SO4; 1×O9A; | 6pdg | |
Assess | ||||
Crystal structure of MYST acetyltransferase domain in complex with Acetyl-CoA cofactor | monomer | 1×ZN; 3×NA; 1×ACO; 1×7L1; | 6ba4 | |
Assess | ||||
Crystal structure of MYST acetyltransferase domain in complex with inhibitor 42 | monomer | 1×ZN; 1×NA; 2×GOL; 1×SO4; 1×O9P; | 6pdc | |
Assess | ||||
Crystal structure of MYST acetyltransferase domain in complex with inhibitor 92 | monomer | 1×ZN; 2×GOL; 1×NBJ; 1×DMS; | 6owh | |
Assess | ||||
Crystal structure of MYST acetyltransferase domain in complex with inhibitor 62 | monomer | 1×ZN; 1×MNJ; 1×GOL; | 6oir | |
Assess | ||||
Crystal structure of MYST acetyltransferase domain in complex with inhibitor 41 | monomer | 1×ZN; 1×NA; 1×O9S; 2×GOL; 1×SO4; | 6pdd | |
Assess | ||||
Crystal structure of MYST acetyltransferase domain in complex with inhibitor 55 | monomer | 1×ZN; 1×NA; 2×GOL; 1×SO4; 1×O9Y; | 6pdf | |
Assess | ||||
Crystal structure of MYST acetyltransferase domain in complex with inhibitor 40 | monomer | 1×ZN; 1×NA; 2×GOL; 1×SO4; 1×O9V; | 6pde | |
Assess | ||||
Crystal structure of MYST acetyltransferase domain in complex with inhibitor 80 | monomer | 1×ZN; 1×NA; 2×GOL; 1×SO4; 1×O9M; | 6pdb | |
Assess | ||||
Crystal structure of MYST acetyltransferase domain in complex with inhibitor 74 | monomer | 1×ZN; 1×NA; 2×GOL; 1×SO4; 1×O9J; | 6pda | |
Assess | ||||
Crystal structure of MYST acetyltransferase domain in complex with inhibitor 39 | monomer | 1×ZN; 1×NA; 2×GOL; 1×O9D; | 6pd8 | |
Assess | ||||
Crystal structure of MYST acetyltransferase domain in complex with inhibitor 60 | monomer | 1×ZN; 1×NA; 2×GOL; 1×O9G; | 6pd9 | |
Assess | ||||
MYST histone acetyltransferase 1 | monomer | 1×ZN; 1×COA; 13×UNX; | 2pq8 | |
Assess | ||||
Crystal structure of MYST acetyltransferase domain in complex with inhibitor 85 | monomer | 1×ZN; 1×NB7; 1×GOL; | 6owi | |
Assess | ||||
Human MYST histone acetyltransferase 1 | monomer | 1×ZN; 1×CL; 1×ACO; | 2giv | |
Assess | ||||
Human MOF C316S, E350Q crystal structure | monomer | 1×ZN; 2×CL; 2×NA; | 5j8c | |
Assess | ||||
The Crystal Structure of human MYST1 from Wuxi Biortus. | monomer | 1×ZN; 1×GOL; | 7cmr | |
Assess | ||||
Human MOF K274P crystal structure | monomer | 1×ZN; 2×CL; | 5j8f | |
Assess | ||||
Human MOF E350Q crystal structure with active site lysine partially acetylated | monomer | 1×ZN; 1×CL; | 3tob | |
Assess | ||||
Human MOF crystal structure with active site lysine partially acetylated | monomer | 1×ZN; 2×CL; 2×EDO; | 3toa | |
Assess |
Homology models built on isoform sequence
Isoform | Oligo-state | Ligands | QMEAN | Template | Range | Seq id (%) |
---|---|---|---|---|---|---|
Isoform 2 | monomer | 1×ZN; | -0.86 | 4dnc.1.A | 96.75 | |
Assess |